The one-day workshop was the 2nd of a series of workshops in support to the Council Recommendation of December 2009 that encourages EU and EEA Member States to adopt and implement action plans or policies to improve seasonal influenza vaccination coverage.
The World Health Organization (WHO) recently recommended using the same three flu strains in next year's Southern Hemisphere (SH) vaccine as are in the current Northern Hemisphere vaccine and were used last year in southern hemisphere countries.
The 1918 pandemic continues to provide a rich source of studies of the clinical impact of those novel viruses which between 1918 and 1920 killed up to 50 million people world-wide. These two recent studies first shows autopsy results among military recruits who died from the first influenza pandemic of the 20th century and the second suggests the impact on births.
Topics covered includeed: Human seasonal influenza programme planning; Surveillance systems and epidemiological studies; Laboratory issues; Human seasonal influenza policy; Vaccination; Targeting priority groups; Communication; Evaluation and research of human seasonal influenza and Action planning.
ECDC has organised the “Influenza Workshop Week” to support Member States and the European Commission in implementing the 2009 EU Council Recommendation on Seasonal Influenza Immunisation.
Rotavirus gastroenteritis in Ireland is a quite common and unpleasant illness, but severe disease is unusual and death extremely rare. Nonetheless, rotavirus generates considerable direct and indirect costs.
The 2011 seasonal influenza immunisation campaigns have started across Europe. As in previous years ECDC is marking the start of the 2011-12 surveillance season in Week 40 with the publication of regular weekly updates of the main epidemiological and virological developments in the Weekly Influenza Surveillance Overview (WISO).
At his annual hearing with the European Parliament’s Committee on the Environment, Public Health and Food Safety, ECDC Director Marc Sprenger described the resurgence of measles in the EU as “one of the major events of this new decade”.
On 3 October 2011 European Centre for Disease Prevention and Control (ECDC) and representatives of the European Vaccine Manufacturers met at ECDC in Stockholm for a regular scheduled meeting about the use of vaccines for prevention of seasonal and pandemic influenza. ECDC Director Marc Sprenger opened the meeting and ECDC influenza experts held different presentations, such as burden of influenza disease in the EU, risk groups for severe influenza disease, personal protective measures, pandemic influenza preparedness, seasonal influenza vaccines, communication.
The Declarations of Interest for ECDC Influenza Staff and the ECDC Director are available here under ECDC Transparency.